Dynamic protein S-palmitoylation concerns the addition of palmitate to cysteines of the modified protein by zDHHC palmitoyl transferases (PATs) through thioester linkages and depalmitoylation by palmitoyl protein thioesterases (PPTs) ([@B5]). Protein S-palmitoylation cycles promote the insertion of target proteins into membranes, regulating their localisation and function ([@B15]).

PATs are key transmembrane enzymes, with cysteine rich domains in the DHHC motif (CRD-DHHC domain), in addition to DPG and TTxE structural domains ([@B12]). PATs are involved in diverse biological processes in several organisms, such as *Homo sapiens* cancer ([@B7]) and neurological diseases ([@B22], [@B4]), yeast endocytosis ([@B9]), *Cryptococcus neoformans* virulence ([@B21]), *Giardia lamblia* encystation ([@B18]) and invasion in Apicomplexa ([@B10]). TbPAT7 is responsible for flagellar localisation of calflagin in the trypanosomatid protozoan *Trypanosoma brucei* ([@B8]).

PPTs belong to the serine hydrolases family, are less abundant in number than PATs and are characterised by the presence of a serine active site for hydrolysis of the substrate, being able to cleave amide, ester and thioester bounds ([@B17]).

[@B11]) identified, by *in silico* search, 15 PATs in the *Trypanosoma cruzi* genome, as opposed to 12 in *T. brucei* and 20 in *Leishmania major*. However, up to now only one PAT has been characterised in *T. cruzi*, the etiological agent of Chagas disease: TcHIP, or TcPAT1 ([@B1]). TcPAT1 is a 95.4 kDa Golgi protein expressed in different developmental stages of the parasite, with a modified DHYC motif ([@B1]). Such modified motif is functional in the homologue Akr1p enzyme of *Saccharomyces cerevisae* ([@B20]).

It has been recently shown that dynamic protein S-palmitoylation is involved in life cycle progression and virulence in some pathogenic protozoa ([@B3]). However, no evidence of global PATs or PPTs expression has been yet reported in *T. cruzi*. Thus, aim of this work was to verify the expression of dynamic protein S- palmitoylation enzymes in *T. cruzi* Dm28c ([@B6]) epimastigote forms. An *in silico* search for PATs was made in the *T. cruzi* genomic data base (TritrypDB), in parallel with nucleotide BLAST alignment (nBlast-NCBI, Bethesda, MD, USA) of *T. cruzi* genes with the well characterised *S. cerevisiae* PAT genes that encode for Erf2 (with DHHC-CRD motif) ([@B16]) and Akr1p (with DHYC-CRD motif) ([@B20]). As a result, 15 PATs genes were found, identical to that formerly identified by [@B11]). Size of these genes varied from 768 (TcPAT7) to 2610 (TcPAT1) base pairs and the resulting protein products were between 30 and 95.4 kDa. Sequence identity between the TcPATs was very low, between 14.2% and 26.83%, as assessed using multiple alignment with Clustal Omega (EMBL-EBI, Cambridgeshire, UK). The softwares TMHMM Server v. 2.0 (Center for Biological Sequence Analysis, CBS, Lyngby, Denmark) and Phyre2 ([@B13]) were used to predict transmembrane regions and calculate 3D protein models, respectively. It could be determined that these proteins had three (TcPATs 2 and 6) to seven (TcPAT5) transmembrane domains. By using pFAM software (Sanger Institute, Cambridge, UK) to predict protein domains, it was found that only TcPAT1 had the DHYC motif, while the number of cysteines close to the DHHC/DHYC motif varied from 5 to 9. Only TcPAT4, TcPAT10 and TcPAT14 had both DPG and TTxE structural motifs. On the other hand, TcPATs 5 and 9 had only the DPG motif, while TcPATs 1, 7 and 8 had only the TTxE motif ([Fig. 1](#f1){ref-type="fig"}).

![identification and *in silico* analysis of *Trypanosoma cruzi* PATs. Fifteen TcPATs were identified, with predicted molecular mass from 30 to 95.4 kDa. All proteins had transmembrane domains and contained the DHHC motif, with the exception of TcPAT1 (DHYC). S1-SN: membrane crossings; kDa: molecular weight of the predicted protein; TTxE and DPG: structural motifs.](0074-0276-mioc-113-08-e180086-gf01){#f1}

All TcPATs showed similar predicted 3D models, except for TcPAT1 (larger and with ankyrin repeats). TcPPTs 1 and 2 were very different from each other. All 3D models had 100% confidence ([Fig. 2](#f2){ref-type="fig"}).

![predicted 3D models of *Trypanosoma cruzi* PATs and PPTs. The software Phyre2 was used. All 3D models had 100% confidence.](0074-0276-mioc-113-08-e180086-gf02){#f2}

Aiming to produce transfectant cell lines of *T. cruzi* epimastigotes expressing TcPATs plus a FLAG tag at the C terminus (FLAGC tagged TcPAT), the genes were amplified using specific primers ([Table I](#t1){ref-type="table"}) with recombination sites for the Gateway cloning platform (Thermo Fischer Scientific, Waltham, MA, USA) by using the entry plasmid vector pDONR 221 and the destination *T. cruzi* vector pTcGWFLAGC ([@B2], [@B14]). All genes were cloned, except TcPAT6 and TcPAT1 (already characterised). Three-day-old *T. cruzi* epimastigotes were transfected with a Gene Pulser XCell BIORAD electroporator (BIORAD Inc., Hercules, CA, USA), selected with 500 µg.mL^-1^ G418 and maintained with 250 µg.mL^-1^ of the same antibiotic, as previously described ([@B2]). Twelve resistant cell lines could be selected, with the exception of TcPAT4.

###### Primers used for palmitoyl transferase (PAT) isolation from gDNA of *Trypanosoma cruzi* (clone Dm28c) epimastigotes

  -------------------------------------------------------------------------------------------------
  PAT/Gene ID                               F'/R' (5'-3')
  ----------------------------------------- -------------------------------------------------------
  TcPAT1/[\*](#TFN1){ref-type="table-fn"}   ATGCAGGTGTTTGGCGCTCGGATG\
                                            ACGGCGTTCATCTTTCACCT

  TcPAT2/ TcCLB.506297.250                  ATGCCACAGACTAACAGCACGGAATGG/GGGTTCTCTGACTTCATGCGC

  TcPAT3/ TcCLB.510899.50                   ATGGGGCCCATACGCGTTGAAAGAG/CACCTGCGTGGCACACAACT

  TcPAT4/ TcCLB.508479.200                  ATGTCAGGTTTCTGGTCTGTTCAGC/CACCTCTGCTGTTTCAACGACAATAT

  TcPAT5/ TcCLB.509029.170                  ATGTCCGGAGAGACTTTTGCTTG/CTCATATTTCATCCTCCGTTCTCCT

  TcPAT6/ TcCLB.506177.40                   ATGCGGTCATCTATGTTGCTGCTTTT/TTCCTCCTTCATCTCCTCCTCGCT

  TcPAT7/ TcCLB.510687.130                  ATGGATGAATCAAACGACGCG/CACGTCATTCTCAGCGTTTCG

  TcPAT8/ TcCLB.511897.19                   ATGGGTAAGATTTTTGAAATGGAGGT/CCGTATCAAATCAACAAGAGTTCTCC

  TcPAT9/ TcCLB.509769.33                   ATGGATTGCGTGGTAGGTATGCGGAAT/AACTAGAGCCTCAGTGTTCAACCAC

  TcPAT10/ TcCLB.508239.40                  ATGATGTCATTGTTATCACGATGGG/CACAAGGTCGGCGTCATCG

  TcPAT11/ TcCLB.511823.50                  ATGTCGTTGCTTTGTTGTGATCC/GTCATATTTGGGTGAAATGGGTG

  TcPAT12/ TcCLB.506855.10                  ATGGGGTCGTTGATTCCGC/CACCGGCAACATCACCTCATC

  TcPAT13/ TcCLB.510747.18                  ATGAATGTACCCACTTCATCCAGTCCGAT/CACATAAAACTCGGCGTTTTCC

  TcPAT14/ TcCLB.511153.60                  ATGGAGTCCGTGGAAGTGCTAGT/TGCGATGATGGGGCTCTTATT

  TcPAT15/ TcCLB.509105.20                  ATGCGGTGCTGTGGGCG/CATACCACCAGATCCGGGAAGCGAC
  -------------------------------------------------------------------------------------------------

[@B1]); F': forward primer; R': reverse primer.

For subcellular localisation by indirect immunofluorescence assays (IFA), *T. cruzi* transfectants were washed twice in PBS, fixed for 10 min with 4% paraformaldehyde, adhered to 0.1% poly-L-lysine coated coverslips, permeabilised with 0.5% Triton/PBS, and incubated for one hour at 37ºC using a mouse anti-flag antibody (Sigma-Aldrich St. Louis, MO, USA) diluted 1:4000 in incubation buffer (PBS pH 7.4 containing 1.5% bovine serum albumin). After three washes in PBS, the samples were incubated in the same conditions with a secondary goat anti-mouse antibody coupled to AlexaFluor 594 (Thermo Fischer Scientific, Waltham, MA, USA) diluted 1:600 in incubation buffer. The samples were washed three times with PBS, incubated for 5 min with 1.3 nM Hoechst 33342 (Sigma-Aldrich St. Louis, MO, USA) and the coverslips were mounted with Prolong Gold antifading agent (Thermo Fischer Scientific, Waltham, MA, USA). The slides were observed in a Nikon Eclipse E600 epifluorescence microscope.

As a result, TcPATs 3, 5, 8, 11, 12, 14 and 15 were located as single dots at the anterior region of the parasite, close to the kinetoplast and the flagellar pocket ([Fig. 3](#f3){ref-type="fig"}). Interestingly, most PATs with four transmembrane domains (five out of seven) showed this pattern. The positive reaction was frequently found lateral to the kinetoplast, which suggests Golgi, flagellar pocket or contractile vacuole localisation. TcPAT2 labeling appeared as strong dots distributed throughout the cell body, suggestive of localisation in some cytoplasmic organelle ([Fig. 3](#f3){ref-type="fig"}). TcPAT13 presented a stronger labeling at the perinuclear region ([Fig. 3](#f3){ref-type="fig"}). These patterns were expected, since PATs are usually found at the endoplasmic reticulum, Golgi and plasma membranes ([@B19]). No positive reaction was detected for TcPATs 7, 9, 10 ([Fig. 3](#f3){ref-type="fig"}). Transcriptomic data from TritrypDB indicate that TcPATs 7 and 9 are expressed in metacyclic trypomastigotes, but not in epimastigotes. Therefore, gene expression of these two enzymes (and possibly also TcPAT10) can be down-regulated in epimastigotes. In summary, these results indicated that at least nine TcPATs could be overexpressed in *T. cruzi* epimastigotes.

![localisation of FLAG tagged PATs and PPTs in *Trypanosoma cruzi* epimastigotes by immunofluorescence assay. Control: wild type epimastigote; blue: hoechst staining of nucleus (n) and kinetoplast (k) DNA; red: PAT (arrow) and PPT labeling with AlexaFluor 594. Bars = 5 µm.](0074-0276-mioc-113-08-e180086-gf03){#f3}

In order to characterise the TcPPTs, a genomic data search was performed as described above, and two genes were identified ([Table II](#t2){ref-type="table"}). TcPPT1 is an 843 base pairs gene and the product (30.2 kDa) is homologue to *H. sapiens* acyl-protein thioesterase-1 (APT1) and lysophospholipase genes, which are involved in cytosolic and lysosomal protein depalmitoylation ([@B17]). TcPPT2 is a 951 base pairs gene and the product (35.5 kDa) is homologue to *H. sapiens* acyl-protein thioesterase-2 (APT2), involved in cytosolic depalmitoylation ([@B17]). Primers were then designed for isolation and amplification of these genes ([Table II](#t2){ref-type="table"}).

###### Identification, *in silico* analysis and primer design of *Trypanosoma cruzi* palmitoyl thioesterase (PPT)

  -----------------------------------------------------------------------
  PPT/Gene ID                BP    kDa    F'/R' (5'-3')
  -------------------------- ----- ------ -------------------------------
  TcCLB.506797.70 (TcPPT1)   843   30.2   ATGATCGGAACGCCGATAGAAAACT/\
                                          AGCCTTGGACTCAATCGCCGGCAATACCT

  TcCLB.504149.55 (TcPPT2)   951   35.5   ATGCTTCTGCAGGACGTTATTGGAG/\
                                          GAGTCTCGATTTGTAGCCCTTTCCTG
  -----------------------------------------------------------------------

BP: number of base pairs; kDa: molecular weight of the predicted protein; F': forward primer; R': reverse primer.

The same steps described above for TcPATs were used to produce *T. cruzi* cell lines expressing TcPPTs plus a FLAG tag at the C terminus (FLAGC tagged TcPPTs). Resistant cell lines expressing TcPPT1 and TcPPT2 were selected with 500 µg.mL^-1^ G418. After IFA in the same conditions as described above, both TcPPTs showed strong labeling dispersed through the cell body, suggesting a cytoplasmic localisation ([Fig. 3](#f3){ref-type="fig"}), indicating that *T. cruzi* epimastigotes overexpressed both TcPPTs, in the expected cytoplasmic localisation.

In conclusion, our data indicate that a dynamic protein S-palmitoylation machinery (nine PATS and two PPTs) could be overexpressed in *T. cruzi*. Future studies will be crucial to determine the importance of this machinery for the parasite survival. Palmitoylation and depalmitoylation of proteins can play an important role in this parasite, in events as diverse as nutrition, protein traffic, differentiation, host-cell interaction and infection establishment.
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